Randox Toxicology Highly Sensitive ELISA kits
Randox Toxicology Highly Sensitive ELISA kits
Enzyme-linked immunosorbent assay, or ELISA, has been utilised as a screening tool for some time. The immunoassay technique is a popular choice for the evaluation of various research and diagnostic targets including drugs of abuse testing.
As primary manufacturer of the Biochip Array Technology, Randox Toxicology also provide highly sensitive ELISA kits that are compatible with all microplate processing instruments. Our test menu covers a broad range of drugs of abuse and metabolites including new psychoactive substances, stimulants, analgesics and sedatives. With low specificity, our ELISA kits are available across whole blood, urine and oral fluid matrices. Randox Toxicology develop the highest quality 96-well microtitre plates available on the market, with results providing excellent correlation with confirmatory methods.
Our range of ELISAs are precoated with our own antibodies which are cultivated in the UK. The ready to use reagent format facilitates optimum laboratory efficiency and allows up to 80 samples to be analysed in 2 to 3 hours with ELISA procedures.
* EXCLUSIVE to Randox Toxicology
For more information on our ELISA solutions email info@randoxtoxicology.com to be put in touch with a sales member in your area or visit www.randoxtoxicology.com.
We Are Randox | ‘Tis the Season of Giving at the Christmas Raffle 2018
This year our much-anticipated Christmas Raffle took place on Monday 24th December 2018, in aid of our official charity partners, AWARE NI and Mind Your Mood.
The main depression charity for Northern Ireland, AWARE has an established network of 24 support groups in rural and urban areas across the country, and also delivers mental health and well-being programmes into communities, schools, colleges, universities and workplaces. Mind Your Mood is an initiative designed and managed by students at Ulster University to help break down the stigma of mental health and encourage students to access support.
Did you know that the prevalence of mental health conditions in Northern Ireland is up to 25% higher than in England, with anxiety and depression being the most common mental disorders? We’re proud therefore to be supporting both AWARE and Mind Your Mood with a range of fundraising initiatives this year, including now the Randox Christmas Raffle 2018, at which, we are delighted to announce, we raised more than £2500 – with the official total still to be counted!
Congratulations to all our prize winners from this year’s Christmas Raffle, and in particular to the lucky winners of our most coveted prizes – a 55″ Ultra HD 4K Sony Bravia TV and an extra day of annual leave!
Randox Food Diagnostics Screening for Coccidiostats
Feed additives are important in modern agriculture and a focus of the European Union (EU) framework. Whilst such products are used to improve the characteristics of feed, any company wanting to use feed additives for the EU market must obtain prior authorisation, during which the European Food Safety Authority (EFSA) evaluates the safety and efficacy of each additive. The European legislation on animal feed ensures that feedstuffs are suitable for human and animal consumption, whilst not damaging the environment.
Coccidiosis is a disease caused by coccidian, which multiplies in the intestines. In the acute form death of a bird can occur in five to seven days, whilst the chronic type does not kill immediately but persists for a long period of time. To prevent infection, farmers may administer prophylactic antiprotozoal coccidiostats in feed, which increases the chance that coccidiostat residues are retained in both poultry meat and eggs.
However, coccidiostat levels in poultry have increased significantly over the past 3-4 years, causing concern among various groups including Save Our Antibiotics. To reduce the risk of toxicity to consumers, regulatory authorities have set Maximum Residue Limits (MRLs) recommending an appropriate withdrawal period prior to slaughter.
The Randox Food Diagnostics coccidiostats array utilises Biochip Array Technology to quantitatively test for multiple analytes including lasalocid, nicarbazin and imidocarb simultaneously. Revolutionising screening practices, Biochip Array Technology is designed to work across a wide variety of matrices and provides up to 44 results in under 3 hours, saving the user both time and money compared to other screening methods.
For more information on our extensive test menu and coccidiostats array email us directly at: info@randoxfooddiagnostics.com
We Are Randox | Randox mentor recognised at QUB 2018 Placement Awards
A senior manager at global healthcare diagnostics company Randox Laboratories has been recognised by Queen’s University Management School with a prestigious award.
Presented with the accolade at the Management School Placement Awards Event 2018, Financial Controller Mary McAllister was nominated by QUB student Bronagh McCarron who had completed her placement year at Randox in the company’s finance office.
Mary McAllister, Senior Financial Controller at Randox Laboratories, and recipient of the QUB Management School Mentor Recognition Award, commented;
“As an incredibly hard-working, diligent and enthusiastic placement student, Bronagh was a valued member of the Randox Finance Team. I’m delighted therefore, that this Mentor Recognition Award represents that equally, Bronagh really valued her time with us at Randox. With extensive training, support, trust and encouragement, we’re proud to be playing a significant part in the development of the next generation of QUB graduates.”
The Mentor Recognition Award seeks to acknowledge individuals within QUB’s placement employer partners who establish an organised, supportive and beneficial placement environment, which engages, motivates and inspires students during their time in industry.
Bronagh McCarron, Randox Finance Placement and Student at QUB Management School said;
“Throughout my placement year Mary was always incredibly approachable for any problems or queries I had. Asking questions was always encouraged and I never felt like I couldn’t speak up to seek guidance on any of the tasks I had within the Randox Finance department. It’s thanks to Mary and all of my Randox colleagues that I enjoyed my placement year so much and now have more faith in my abilities as I return to university for my final year of studies.”
The Queen’s Management School Placement Programme has been running for more than 25 years, with the aim of empowering students to develop their employability skills. Students are encouraged to identify their career aspirations, reflect on their skills, and find areas of development in order to meet the needs of an ever competitive graduate labour market.
Bronagh added;
“During my time with the Accounts team at Randox, I worked on both the Accounts Receivable for our headquarters office, and on the Accounts Payable for our Randox Teoranta site in Dungloe, Donegal. This variety of work gave me plenty of exposure to the different aspects of Accounts Management. I was involved in communication with both customers and suppliers from a wide range of companies, from which no one query was the same. It has massively increased my confidence working in a business environment.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“At Randox we are great advocates of placement during a student’s time in education. It gives Randox the opportunity to work with ambitious and bright young people from across Northern Ireland and in turn we can help to nurture their potential and provide them with industry experience. I’m very proud therefore that Mary’s dedication and commitment to the placement students placed in her care has been formally recognised by Queen’s University Belfast and on behalf of everyone at Randox would like to pass on our congratulations for being awarded this impressive prize.”
For further information about the QUB Management School Placement Awards please contact Randox PR by emailing randoxpr@randox.com
We Are Randox | Christmas Jumper Day in aid of Save the Children
It was beginning to look a lot like Christmas at Randox today as colleagues donned their favourite festive knit in aid of Save the Children’s Christmas Jumper Day.
Staff members across Randox UK got involved in the winter fundraiser – from Crumlin to London and Liverpool to Holywood.
If you’d like to donate to Save the Children, please text TEAM RANDOX to 70050 and a £2 donation will go to Save the Children plus your standard message rate.
#WeAreRandox
Randox Testing Services Complete Drug and Alcohol Testing Solutions
At Randox Testing Services we provide reliable and cost-effective employee testing for a wide range of industries including aviation, maritime, manufacturing and many more. We cater to all business needs and offer workplace drug and alcohol testing across a variety of testing types.
We understand the needs of different industries can vary from one extremity to the other so our expertise allows us to craft customised packages to meet the needs of any workplace.
Implementation of an effective substance misuse policy establishes employer rights to conduct workplace drug and alcohol testing if required. In addition, it ensures adherence to the duty of care of an employer to protect their workforce and keep employees safe.
Types of Testing
- Pre-Employment Testing
This is used as an indicator of candidate suitability, it forms an essential part of a company’s recruitment process, and helps maintain the safety of the firm’s current workforce.
- Random Testing
With knowledge that a test could be conducted with anyone at any time, random testing is the most effective deterrent of drug or alcohol misuse among employees. It ensures integrity of staff across all levels and can be conducted with employees at any level from temporary staff to directors.
- With-Cause Testing
This is conducted when there is suspected drug or alcohol abuse in the workplace, whether allegations are made, suspicion arises, if drugs and alcohol have been found in work or following an accident.
- Post-Incident Testing
Post-Incident testing occurs after an accident or incident in work to determine if drugs or alcohol may have contributed to the cause.
- Abstinence Testing
The process of this testing is conducted in circumstances where an employee, having tested positive for a previous drug or alcohol test is monitored to ensure they remain abstinent from drug or alcohol misuse.
Sample Types
Randox Testing Services utilises discreet and non-invasive methods of drug testing for patient comfort and fast sample collection. Offering a choice of a urine test, hair drug test, saliva drug test or a combination. Our drug testing methods ensure the possibility for short-term and long-term drug abuse profiling. With different drug testing methods having different windows of drug detection, we can provide advice on which methods to utilise depending upon your organisation’s drug testing requirements. This ensures the best method or combination of methods is chosen to ensure all needs of the business are met. Click the link to find out more about each sample type and their detection windows. https://bit.ly/2DePPD4
Procedure
To enable reliable results, our drug and alcohol screening procedure is coherent with a strict chain of custody procedures to ensure sample integrity and traceability from point of collection to result reporting.
The process of testing;
- Initial Consultation with Randox Testing Services
We begin with a free consultation with one of our experienced business development executives. During this we will discuss your testing requirements and put together a package tailored to meet the needs of your business.
- Create a Workplace Drug and Alcohol Testing Policy
Providing you with the correct tools and information, we ensure you have an effective policy in place to allow you the right, an employer, to carry out employee testing. We also ensure the rights of the employee are protected by ensuring a policy which is clear and concise. During this process, we will discuss the types of workplace testing you wish to carry out ensuring your policy suits the business needs.
- Implement Workplace Drug and Alcohol Testing
We provide comprehensive training and education to help you communicate the new policy to your employees and management staff.
- Sample Collection
Once consent from employees is given our network of trained and experienced sample collection officers collect samples using your chosen method of testing at a time and location that suits. We also offer training and education to your own staff to collect samples from employees. Throughout sample collection, sample integrity is maintained following strict chain of custody criteria.
- Sample Analysis
Employee samples are transported to our state-of-the-art laboratory. Upon arrival, they are assessed to ensure sample integrity has been maintained, they are then screened using our innovative Biochip Array Technology to ensure accurate and reliable results. Upon analysis of employee samples, required actions will differ depending on the result:
- Negative
- Presumptive Positive (Indicates presence of a particular substance. Further analysis required).
- Confirmatory Testing (Carried out on presumptive positive samples to confirm drug class and concentration).
- Positive (Received after confirmatory testing, a report detailing drugs present and at what concentration will be written).
- Results Reporting
Results are reported confidentially via our secure web portal. Alternatively, another method can be chosen to suit your needs.
Drugs We Test For
We test for a wide range of drugs of abuse. Our different panels highlight the vast range of substances we are capable of testing for, across both instant testing kits and back to lab panels. Click on the link to see the range of drugs we test via instant or back to lab based on sample type. https://bit.ly/2PMcMVL
Randox Testing Services
Randox Testing Services is a specialist in the drug and alcohol testing industry. We aim to educate and inform companies and customers about the dangers of drugs and alcohol in the workplace.
Contact us today at testingservices@randox.com or call 0 161 741 2760 to speak to one of our experts.
The move from Nephelometry to Immunoturbidimetric Testing
Background
In clinical diagnostics, proteins are part of a wide range of biochemical markers used to identify health and disease in patient samples. Proteins play a key role in the human body, as they are involved in almost every process and can be associated to functions and regulatory pathways that are either signature for disease onset or a target for therapeutic intervention.
There are two main methods used to detect proteins in patient samples; nephelometry and immunoturbidimetry. Nephelometry although traditionally thought to be more sensitive can be expensive due to higher consumable costs. In addition to this nephelometers can be inefficient and are limited by their test menu. Immunoturbidimetric tests are an increasingly accepted alternative to nephelometry for specific protein assays, and studies have shown a close correlation between Randox immunoturbidimetric tests and nephelometry. This particularly lies with the latex enhanced immunoturbidimetry methodology utilised by Randox.
Why the RX series?
Renowned for quality and reliability, the RX series excels in clinical testing combining robust hardware, intuitive software and a world leading test menu featuring routine and novel high performing reagents.
Running specific protein tests on the RX series provides laboratories with a wide range of advantages. The move from nephelometric testing to immunoturbidimetric lowers laboratory costs as nephelometry requires the use of dedicated instruments which are much slower, have higher consumable costs and require highly trained personnel, with the disadvantage of not being able to perform any other type of assay on a single platform.
The RX series improves laboratory efficiencies not just saving costs but also time. Our range of routine clinical chemistry analysers provide users with flexibility and versatility through consolidation of testing onto one single platform.
High Performing and Unique Testing Menu
The RX series of specific protein assays assist in the diagnosis and evaluation of various conditions each with excellent sensitivity and limited inference levels. Randox manufacture immunoturbidimetric kits for the study of a wide range of specific proteins including unique products such as Apolipoprotein C-II, Apolipoprotein C-III, Apolipoprotein E, Cystatin C and Microalbumin.
Most recently the RX series welcomed the addition of Direct HbA1c to our testing panel, available to be run on the RX Daytona +, RX imola and RX modena. If you are interested in running your protein assays on a routine biochemistry analyser, Randox offers a large range of high quality routine and niche protein assays that can be run on most automated analysers.
Click to discover more about our world leading RX series Testing menu or contact us today @theRXseries to find out how we can improve your laboratories testing capabilities.
Randox Biosciences and Metabolic Syndrome
The Evidence Evolution is a fully automated immune-analyser with random access. The machine has the capability to process up to 2640 tests per hour with up to 44 analytes screened per biochip. With a wide range test menu Randox can offer the market the service they expect with state-of-the-art intuitive touchscreen software and advanced precision bio-drive robotics.
Metabolic syndrome is described as a combination of diabetes, high blood pressure and obesity. As result of three health conditions going on, it puts the individual at greater risk of developing coronary heart disease, stroke and many other risks. 1 As well as developing additional health conditions it can cause damage to the blood vessels, the blood pressure damages the blood vessels, the obesity causes a lot of strain on the blood vessels and the heart.2 Therefore, can result in serious long-term risks.
Metabolic disease is very common. Studies state that the serious health condition affects about 23% of adults. 3One in four adults in the UK are currently living with metabolic syndrome and often becomes more common with age2.
Usually it affects those who are overweight or considered obese, have an unbalanced diet containing high levels of sugar and fat and have high cholesterol and extremely high blood pressure2 therefore, the condition can be prevented by reducing the risks.
1 According to the NHS, metabolic syndrome occurs when a person has three or more of the following measurements:
- Abdominal obesity (Waist circumference of greater than 40 inches in men, and greater than 35 inches in women)
- Triglyceride level of 150 milligrams per deciliter of blood (mg/dL) or greater
- HDL cholesterol of less than 40 mg/dL in men or less than 50 mg/dL in women
- Systolic blood pressure (top number) of 130 millimeters of mercury (mm Hg) or greater, or diastolic blood pressure (bottom number) of 85 mm Hg or greater
- Fasting glucose of 100 mg/dL or greater
There are many ways to prevent metabolic syndrome from developing, making lifestyle changes for example, ensuring their weight is healthy by increasing physical exercise, eating a well-balanced healthy diet containing whole grains, fruit, vegetables and fish and finally, visiting the GP to monitor and manage blood glucose, blood cholesterol and blood pressure, quit smoking and managing your stress.
Randox offers the Evidence Evolution including two Metabolic Syndrome Arrays which allows multiplex testing from a single sample allowing rapid turnaround time and are suitable for both serum and plasma samples.
Metabolic Syndrome Array I
- Ferritin
- Interleukin-6 (IL-6)
- Insulin
- Leptin
- Plasminogen Activator Inhibitor-1 (PAI-1)
- Resistin
- Tumour Necrosis Factor α (TNFα)
Metabolic Syndrome Array II
- Adiponectin
- C-reactive Protein (CRP)
- Cystatin C
For more information on our Evidence Series or Metabolic Syndrome Range of Assays, contact us at EvidenceSeries@randox.com
£700,000 UK government investment in Randox R&D
A £700,000 UK Research and Innovation investment into manufacturing processes at Randox means patients could benefit from quicker, cheaper and more consistent diagnosis of diseases.
The announcement comes exactly one year after the government launched its modern Industrial Strategy – the long-term plan to boost productivity by backing businesses to create high-quality, well-paid jobs in every corner of the United Kingdom.
The Industrial Strategy Challenge Fund (ISCF) award, administered by UK Research and Innovation (UKRI), will allow Randox Laboratories to further develop its state-of-the-art ‘freeze-drying’ technology which enables the components of vital diagnostic kits to be manufactured, stored and transported more effectively, producing better and speedier diagnoses.
For the first time it also allows this complicated manufacturing process to be carried out in the UK rather than having to be outsourced to countries such as the United States, bringing more jobs and economic growth. These new genomic analysis tools also have the potential to make a major impact in the global fight against antimicrobial resistance by identifying and quickly sharing information about resistant microbial strains.
More in-depth analysis of biomarkers in blood and other bodily fluid levels will allow better, quicker diagnosis of cancers and a range of other diseases, ranging from respiratory infections to sepsis, such as blood poisoning.
The Secretary of State for Northern Ireland said:
“I am delighted to announce a £700,000k UK Government investment in Randox, a multinational life sciences company in County Antrim. This funding will bring significant benefits to Randox’s vital medical diagnostics and help create well-paid manufacturing jobs in Northern Ireland.
“A year-on from the launch of our Modern Industrial Strategy, this investment highlights the great progress we are making to boost productivity by backing leading businesses and creating high-quality jobs in every corner of the United Kingdom.”
John Penrose, Minister of State for Northern Ireland, who visited Randox today to mark the new investment, said:
“Everyone always says the UK needs more high-tec, high-value added manufacturing and the high-skilled, high-waged jobs it brings. But Randox are actually doing it right here in Northern Ireland. This is properly world leading, cutting-edge industry and I’m delighted that today’s money is helping bring the vision to life.”
Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented:
“Innovative diagnostic technologies are not only capable of diagnosing disease and ill-health at the earliest possible stage, but they also have a real potential to advance personalised medicine. Our commitment to developing new and exciting breakthroughs in science, technology, engineering and manufacturing is therefore matched only, by our passion to transform the life of the patient. Randox is leading the way in moving from a one-size-fits-all approach towards decisions, practices, and products tailored to the needs of the individual and the Industrial Strategy Challenge Fund award brings us one step closer to realising that aim.”
Funded through UK Research and Innovation, the award forms part of the ISCF Early Diagnosis and Precision Medicine programme, focusing on the use of diagnostic information and genetic analysis to drive more personalised healthcare. Innovate UK, now part of UK Research and Innovation, has supported Randox extensively since 2010, helping grow and scale an innovative diagnostics company who are now distributing their products all over the world.
The announcement comes after the government’s announcement of the Life Sciences Sector Deal that will support healthcare innovation and back businesses to create high-paid, high-quality jobs as part of the government’s modern Industrial Strategy. The deal signals a vote in confidence in UK industry, with global biopharmaceutical company UCB investing around £1 billion in research and development.
For further information please contact Randox PR by emailing randoxpr@randox.com
The Gift of Health: FREE Specialised Test with every Everyman or Everywoman purchased in December
This December, treat your friends and family to the greatest gift of all. The gift of health.
Throughout the month, Randox Health are offering a free Specialised Test, Cough, Cold & Flu, with every Everyman or Everywoman Programme purchased.
Examining up to 150 different indicators of health in your body! The programmes are among the most advanced in the world with our Signature Programme being the most advanced, examining up to 350 different indicators of disease and ill-health. This is due to our advanced technology.
The perfect gift, or perhaps Christmas treat for yourself? These 12-month programmes are guaranteed to give you the most advanced picture available of your current health status.
This month, each programme also comes with a free Cough, Cold & Flu check worth £100.
What is the Cough, Cold and Flu check?
In a world where warnings about antibiotic resistance make daily headlines, Randox Health is helping people take back control.
Antibiotics are used to prevent and treat antibiotic infections. But they don’t work for everything. Taking them when we don’t need them can enable dangerous bacteria that lives inside us to become resistant. That means if you need antibiotics in the future, they may not work. As the NHS says, this puts you and your family at serious risk.
Only bacterial infections can be treated with antibiotics, so finding out what’s behind your infection is essential.
With the Randox Health Cough, Cold and Flu test one swab can detect and identify the cause of 21 respiratory infections in just five hours. With this knowledge, you will find out what’s treatment is going to be appropriate for you.
Take the guesswork out of getting better and book your Cough, Cold and Flu test either as a standalone check or for free with or Everyman or Everywoman Programme.
Specialised tests are available at our clinics in London, Liverpool, Holywood and Crumlin, and also through our innovative mobile health clinic. Gift cards can be purchased from as little as £20.
To find out more about the offer or to purchase the most thoughtful of Christmas presents – a gift card for the ‘gift of health’ – please phone our team on 0800 2545 130. You can also drop them an email. info@randoxhealth.com
Archives
- June 2022
- May 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- July 2014
- June 2014